BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia – HarDoctor News, il Blog di Carlo Cottone
Page 14 - Rivista SIMG 1 - Maggio 2023 - web
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Diapositiva 1
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
Long-Acting Dual Bronchodilators - LAMA/LABA Combo ... | GrepMed
LABA/LAMA fixed dose combinations | Download Table
Regulatory status of fixed dose LAMA/LABA combinations | Download Table
LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life | Semantic Scholar
Avances En Respiratorio | LAMA/LABA vs. LABA/ICS: la evidencia Cochrane | Notícias
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
Terapia con LAMA/LABA nelle GOLD 2017 per la BPCO • NCF
Frontiers | Single Inhaler LABA/LAMA for COPD
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Follow Up Treatment | Stiolto® Respimat® Inhalation Spray | HCP
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
ICS/LABA/LAMA si dimostra superiore a LABA/LAMA per la BPCO • NCF
Population-based study of LAMA monotherapy effectiveness compared with LABA/ LAMA as initial treatment for COPD in primary care | npj Primary Care Respiratory Medicine
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
A new alphabet for COPD care | European Respiratory Society
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
